STERIS plc (STE)

Return on equity (ROE)

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Net income (ttm)	US$ in thousands	378,239	566,841	549,926	119,322	107,030	-27,934	-8,139	376,957	243,888	279,070	249,948	285,995	397,400	432,546	422,975	411,886	407,659	393,815
Total stockholders’ equity	US$ in thousands	6,302,160	6,415,400	6,178,070	6,168,290	6,077,200	6,038,310	5,802,060	6,407,550	6,532,360	6,611,190	6,535,640	6,574,580	3,880,990	3,866,990	3,647,140	3,474,660	3,405,360	3,382,680	3,228,670	3,236,900
ROE		6.00%	8.84%	8.90%	1.93%	1.76%	-0.46%	-0.14%	5.88%	3.73%	4.22%	3.82%	4.35%	10.24%	11.19%	11.60%	11.85%	11.97%	11.64%

March 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $378,239K ÷ $6,302,160K
= 6.00%

STERIS plc's return on equity (ROE) has displayed fluctuating performance over the past few quarters. The ROE for the most recent quarter ending March 31, 2024, stood at 6.00%, showing a decrease from the previous quarter's figure of 8.84%. Looking further back, the trend reveals variations in ROE performance, with highs of 11.97% in March 31, 2020, and lows of -0.46% in December 31, 2022.

Overall, STERIS plc's ROE has not exhibited a consistent upward or downward trajectory, indicating potential challenges in consistently generating profits relative to shareholders' equity. It is essential for stakeholders to closely monitor the factors influencing these fluctuations to assess the company's ability to effectively utilize equity capital to generate returns for shareholders.